Dual chamber prefilled syringes market surging at 8.7% CAGR; Driven by robust proliferated penetration of Lyophilized drugs: Fact. MR
19 Apr 2021
With the escalating need for storing unstable pharmaceutical components, the dual chamber prefilled syringes garner attention as excellent sterile drug injector syringes.
The global dual chamber prefilled syringes market is forecast to reach a valuation of US $3300 Million by the end of 2026. Online pharmacies will spearhead sales, even as supply-chain disruptions are witnessed amid COVID-19 pandemic. However, hospital pharmacies will remain dominant sales channel through 2026.
Increasing demand for safe and self-advocating infusible drugs will be critical for dual chamber prefilled syringes market growth. Counterfeiting will be a major hurdle faced by the manufacturers as counterfeit products can have negative effect on human body. This hampers the sales growth.
“Great emphasis is placed on the technological advancement of dual chamber syringes among the market players. They will also be concentrating on expanding their product portfolio and in-depth market research to survive in this rapidly evolving market”, said a lead analyst at Fact.MR in its new study.
Request Sample of the report on the Dual Chamber Prefilled Syringes Market
The dual chamber prefilled syringes market: Key Findings
North America and Europe are the key markets as both regions record increasing incidence of HemophiliaHemophilia, causing higher demand for dual chamber prefilled syringes
Developing countries like China, Brazil and India will offer growth opportunities on account of the expansion of healthcare facilities
Dual chamber prefilled syringes market finds maximum growth in high penetration of Lyophilized drugs as the drug is used in treatment of Hemophilia
Use of glass for manufacturing dual chamber prefilled syringes will continue rising
While online sales are picking up, hospital pharmacies will continue leading as the key sales channel
Explore 86 tables, 72 figures of the study. Request TOC of the report at
The dual chamber prefilled syringes market - Driving Factors
Focus on technological advancements among market players to offer better patient care will remain a chief growth driver
Increasing awareness and rising demand of premium healthcare services in emerging countries are contributing to the growth
Advancement in biologics and need of efficient drug delivery system are creating attractive market opportunities
The dual chamber prefilled syringes market- Major Restraints
High risk of cross contamination during lyophilization is the key area of concern among the dual chamber prefilled syringe manufacturers
High cost associated to separable chamber prefilled syringes hampers the market growth
COVID-19 Impact on the dual chamber prefilled syringes market
COVID-19 pandemic has adversely impacted the global dual chamber prefilled syringes market due to lockdown restrictions disrupting the necessary supply chain of pharmaceutical drugs.
China being the manufacturing hub and provider of pharmaceutical ingredients stopped its manufacturing and export, when the pandemic tightened its noose, which led to shortage of pharmaceutical drugs and damaged the supply chain.
The dual chamber prefilled syringes market is recovering steadily on the back of gradual relaxation of lockdown restrictions and countries taking steps to promote the in-house manufacturing and reduce its dependence on China.
Competitive Landscape
Fact. MR’s report has profiled some of the key players operating in the market. These include Pfizer Inc., Vetter Pharma-Fertigung GmbH & Co. KG, Ypsomed Holding AG, Catalent, Inc., Credence MedSystems, Inc., Otsuka America Pharmaceutical, Bespak Europe Ltd, Gerresheimer AG, Schott AG, Nipro Corporation., West Pharmaceutical Services, Inc., Boehringer Ingelheim GmbH and Amgen Inc.
The main focus of market players is on expanding their product portfolio and keep up to date market research. They are also actively working on designing new dual chamber prefilled syringes with improved stability and safety of unstable drugs.
More Insights on the Dual Chamber Prefilled Syringes Market
Fact.MR, in its new offering, brings to fore an unbiased analysis of the global dual chamber prefilled syringes market. The study divulges compelling insights on the market based on product type (conventional prefilled syringes and safety prefilled syringes) and sales channel (hospital pharmacies, retail pharmacies, and online pharmacies) across six major regions (North America, Latin America, Europe, APEJ, Japan, and Middle East & Africa).
Request more information about Report Methodology
Explore Fact.MR’s Coverage on the Healthcare Domain
Syringes Market: The scope of this Fact.MR report is to analyze the global syringes market for the upcoming decade and provide readers an unbiased and accurate analysis. Medical device manufacturers, research institutes, and raw material suppliers in the global recombinant protein market can benefit from the analysis offered in this report.
Chromatography Syringes Market: A recent report by Fact.MR provides in-depth analysis of the global chromatography syringes market for the upcoming forecast period, and offers pragmatic insights to lead market players towards devising & implementing informed strategies. This report offers a comprehensive analysis, which can be of interest to leading magazines and journals pertaining to health and wellness.
Prefilled Syringes Market: Fact.MR’s global prefilled syringes market research report elucidates on key expansion dynamics expected to outline future growth trajectory. The study considers key statistics pertaining to lucrative segments spread across key geographical locations. Moreover, an in-depth competitive landscape further enhances the reliability of this research study.
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Follow Us: LinkedIn | Twitter
Source: Fact.MR
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.